ThinkstockIdenix Pharmaceuticals Inc. (NASDAQ: IDIX) was the biggest gainer of all listed stocks on Friday with a rally of 40%. Its trading volume of almost 9.2 million shares was almost eight-times the…
ThinkstockEven though the equity strategy team at UBS has downgraded U.S. equities to Neutral from Outperform, they remain very positive on large cap biotechnology names. Acknowledging in their recent report that the…
Jon OggNow that stocks have pulled back and interest rates have risen, investors are looking for more guidance on which stocks they should still buy and which stocks they should sell or…
ThinkstockBiotechnology stocks have had an extremely solid first half of the year. The analysts at Cowen Group point out that expectations are very high and many of the stocks have already made…
ThinkstockOn Friday after the market closed, biotech giant Amgen Inc. (NASDAQ: AMGN) made an unsolicited $120 per share bid for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) that was rejected. The company has now…
ThinkstockThe higher the market climbs, the harder it becomes for investors to find solid stock ideas to add or scale in to their portfolios. With the market currently teetering on what seems…
These are the top analyst downgrades, cautious research notes and stocks to sell from Wall Street for Wednesday, May 29, 2013. They include Comerica, Maxim Integrated, Vertex Pharmaceuticals and SeaWorld Entertainment.
ThinkstockBiotech has strongly outperformed the S&P 500 since January of 2011. The NASDAQ Biotechnology Index (NBI) is up 90%, and the AMEX Biotechnology index (BTK) is up 50%, versus the 28% gain…
thinkstockHere are today’s five biggest gaining stocks at closing: Vertex Pharmaceuticals Inc.(NASDAQ: VRTX) is up 61.9% at $85.60. Desarrolladora Homex (NYSE: HMX) is up 40.2% at $8.16. Novadaq Technologies Inc. (NASDAQ: NVDQ)…
Paul Ausick U.S. equity markets opened mixed this morning as the DJIA was slammed by a number of weak earnings reports both last night and before markets opened this morning. The was no economic…
Investors and traders are usually always on the hunt for fresh research ideas that will lead to higher income or more profits. 24/7 Wall St. reviews many fresh analyst research calls to find…
Jon OggInvestors and traders remain on the lookout for new ideas for profits and income. 24/7 Wall St. looks over numerous research calls to find great ideas from value stocks to growth…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen so far this Tuesday. There is a larger concentration around biotech and emerging pharma this morning, but that is…
Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen in Wall St. research calls this Wednesday. Check Point Software Technologies Ltd. (NASDAQ: CHKP) started as Market Perform at…
The research team at Argus Research is making some changes to its theoretical model portfolios. It is making buy and sell recommendations in the Equity Income, Growth & Income and Mid-Cap Growth…
